Pune's Sahyadri Hospitals partner with ImmunoACT for CAR-T cell therapy to treat certain forms of cancer | Delhi News

“Currently, 35 to 40 hospitals across the country have joined hands with ImmunoACT for CAR-T cell therapy,” said Professor Rahul Purwar, Founder and CEO Chairman of IIT Bombay-incubated company.

Related Keywords

United States ,India ,Pune ,Maharashtra ,Sahyadri ,Karnataka ,Abrarali Dalal ,Shirish Arya ,Shashikant Apte ,Sunil Rao ,Rahul Purwar ,Business Development Corporate Strategy At Immuno ,Head Of The Department Haematology ,Central Drugs Standard Control Organisation ,Indian Express ,Deenanath Mangeshkar Hospital ,Ruby Hall Clinic ,Sahyadri Hospitals ,Bone Marrow Transplant Unit ,Business Development ,Corporate Strategy ,Sahyadri Hospitals Immunoact ,Mmunoact Cart Cell Therapy ,Cart Cell Therapy ,Ahyadri Hospitals Cancer Treatment ,Cancer Treatment ,Une News ,